# Harpoon Therapeutics, Inc.

Harpoon Therapeutics, Inc. is a company headquartered in South San Francisco, CA, United States.

## Company overview

- **Legal name:** Harpoon Therapeutics, Inc.
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** South San Francisco, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001708493

## About

Harpoon Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001708493, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2023-03-27, it reported annual revenue of USD 31,915,000; net income of USD -67,731,000; total assets of USD 73,729,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $31.9M (USD 31,915,000)
- **Net income:** -$67.7M (USD -67,731,000)
- **Total assets:** $73.7M (USD 73,729,000)
- **Cash and equivalents:** $51.6M (USD 51,614,000)
- **Operating cash flow:** -$89.2M (USD -89,182,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $23.7M (USD 23,654,000)
- **Net income:** -$116.7M (USD -116,721,000)
- **Total assets:** $155.5M (USD 155,452,000)
- **Cash and equivalents:** $44.7M (USD 44,687,000)
- **Operating cash flow:** -$122.2M (USD -122,154,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $17.4M (USD 17,444,000)
- **Net income:** -$49.9M (USD -49,908,000)
- **Total assets:** $171.6M (USD 171,592,000)
- **Cash and equivalents:** $21.2M (USD 21,170,000)
- **Operating cash flow:** -$8.6M (USD -8,616,000)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $5.8M (USD 5,777,000)
- **Net income:** -$55.6M (USD -55,572,000)
- **Total assets:** $176.6M (USD 176,604,000)
- **Cash and equivalents:** $88.7M (USD 88,736,000)
- **Operating cash flow:** -$2.9M (USD -2,891,000)

## Recent SEC filings

- Form SC 13G — filed 2024-03-18
- Form 8-K — filed 2024-03-11 — period 2024-03-11 — 8-K
- Form 8-K — filed 2024-03-08 — period 2024-03-08 — 8-K
- Form 8-K — filed 2024-02-28 — period 2024-02-28 — 8-K
- Form SC 13D — filed 2024-02-27
- Form 8-K — filed 2024-02-22 — period 2024-02-21 — 8-K
- Form SC 13G — filed 2024-02-13 — SCHEDULE 13G
- Form 8-K — filed 2024-01-29 — period 2024-01-26 — 8-K
- Form 8-K — filed 2024-01-26 — period 2024-01-25 — 8-K
- Form SC 13D — filed 2024-01-18 — SC 13D
- Form 8-K — filed 2024-01-08 — period 2024-01-07 — 8-K
- Form 8-K — filed 2023-11-28 — period 2023-11-26 — 8-K

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/harpoon-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology